Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers

被引:1
|
作者
de Porras, Vicenc Ruiz [1 ,2 ,3 ]
Font, Albert [1 ,2 ,4 ]
机构
[1] Germans Trias & Pujol Res Inst IGTP, CARE Program, Badalona 08916, Spain
[2] Catalan Inst Oncol, Badalona Appl Res Grp Oncol B<middle dot>ARGO, Badalona 08916, Spain
[3] Univ Barcelona, Dept Farmacol, Grp Recerca Toxicol GRET, Fac Farm & Ciencies Alimentacio,Unitat Toxicol,Dep, Avda Joan XXIII S-N, Barcelona 08028, Spain
[4] Catalan Inst Oncol, Med Oncol Dept, Badalona 08916, Spain
关键词
D O I
10.3390/ijms242115795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
    Yuhe Huang
    Weiqi Hong
    Xiawei Wei
    Journal of Hematology & Oncology, 15
  • [2] The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
    Huang, Yuhe
    Hong, Weiqi
    Wei, Xiawei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [3] Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
    Hashemi, Mehrdad
    Rezaei, Mahdi
    Rezaeiaghdam, Hadi
    Jamali, Behdokht
    Koohpar, Zeinab Khazaei
    Tanha, Mahsa
    Bizhanpour, Anahita
    Asadi, Saba
    Jafari, Ali Moghadas
    Khosroshahi, Elaheh Mohandesi
    Eslami, Maedeh
    Salimimoghadam, Shokooh
    Nabavi, Noushin
    Rashidi, Mohsen
    Fattah, Eisa
    Taheriazam, Afshin
    Entezari, Maliheh
    TRANSLATIONAL ONCOLOGY, 2024, 50
  • [4] Metabolic Targeting of Cancers: From Molecular Mechanisms to Therapeutic Strategies
    Sheng, Huaming
    Niu, Ben
    Sun, Hongbin
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (13) : 1561 - 1587
  • [5] Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
    Yoshida, Go J.
    Azuma, Arata
    Miura, Yukiko
    Orimo, Akira
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [6] Recent advances in tumor hypoxia: Tumor progression, molecular mechanisms, and therapeutic implications
    Zhang, Yuqing
    Li, Min
    Yao, Qizhi
    Chen, Changyi
    MEDICAL SCIENCE MONITOR, 2007, 13 (10): : RA175 - RA180
  • [7] Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers
    Donovan, Michael J.
    Cordon-Cardo, Carlos
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (08) : 1023 - 1031
  • [8] Correction to: Melatonin and urological cancers: a new therapeutic approach
    Mohammad Hossein Pourhanifeh
    Azam Hosseinzadeh
    Kobra Bahrampour Juybari
    Saeed Mehrzadi
    Cancer Cell International, 20
  • [9] The metabolic landscape of urological cancers: New therapeutic perspectives
    Miranda-Goncalves, Vera
    Lameirinhas, Ana
    Henrique, Rui
    Baltazar, Fatima
    Jeronimo, Carmen
    CANCER LETTERS, 2020, 477 : 76 - 87
  • [10] Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
    Yin, Xiaomin
    He, Zhilong
    Chen, Kun
    Ouyang, Kai
    Yang, Changxuan
    Li, Jianjun
    Tang, Hailin
    Cai, Manbo
    FRONTIERS IN PHARMACOLOGY, 2024, 15